GB0425196D0 - Gastrin and cholecystokinin receptor ligands - Google Patents
Gastrin and cholecystokinin receptor ligandsInfo
- Publication number
- GB0425196D0 GB0425196D0 GB0425196A GB0425196A GB0425196D0 GB 0425196 D0 GB0425196 D0 GB 0425196D0 GB 0425196 A GB0425196 A GB 0425196A GB 0425196 A GB0425196 A GB 0425196A GB 0425196 D0 GB0425196 D0 GB 0425196D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- gastrin
- receptor ligands
- cholecystokinin receptor
- cholecystokinin
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0425196A GB0425196D0 (en) | 2004-11-15 | 2004-11-15 | Gastrin and cholecystokinin receptor ligands |
| PCT/GB2005/004359 WO2006051312A1 (en) | 2004-11-15 | 2005-11-14 | Gastrin and cholecystokinin receptor ligands |
| GB0711660A GB2435190A (en) | 2004-11-15 | 2007-06-15 | Gastrin and cholecystokinin receptor ligands |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0425196A GB0425196D0 (en) | 2004-11-15 | 2004-11-15 | Gastrin and cholecystokinin receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0425196D0 true GB0425196D0 (en) | 2004-12-15 |
Family
ID=33523766
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0425196A Ceased GB0425196D0 (en) | 2004-11-15 | 2004-11-15 | Gastrin and cholecystokinin receptor ligands |
| GB0711660A Withdrawn GB2435190A (en) | 2004-11-15 | 2007-06-15 | Gastrin and cholecystokinin receptor ligands |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0711660A Withdrawn GB2435190A (en) | 2004-11-15 | 2007-06-15 | Gastrin and cholecystokinin receptor ligands |
Country Status (2)
| Country | Link |
|---|---|
| GB (2) | GB0425196D0 (en) |
| WO (1) | WO2006051312A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014026997A1 (en) | 2012-08-16 | 2014-02-20 | Bayer Pharma Aktiengesellschaft | 2,3-benzodiazepines |
| CA2901352A1 (en) | 2013-02-19 | 2014-08-28 | Bayer Pharma Aktiengesellschaft | Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines |
| US20150376196A1 (en) | 2013-02-22 | 2015-12-31 | Bayer Pharma Aktiengesellschaft | 4-substituted pyrrolo- and pyrazolo-diazepines |
| EP2958922A1 (en) | 2013-02-22 | 2015-12-30 | Bayer Pharma Aktiengesellschaft | Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases |
| US10709714B2 (en) | 2013-11-22 | 2020-07-14 | Clifton Life Sciences LLC | Gastrin antagonists for treatment and prevention of osteoporosis |
| WO2015121226A1 (en) * | 2014-02-13 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | 6-substituted 2,3-benzodiazepines |
| WO2017005711A1 (en) * | 2015-07-09 | 2017-01-12 | Bayer Pharma Aktiengesellschaft | Phosphorous-and sulfur-substituted benzodiazepine derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993012817A1 (en) * | 1991-12-20 | 1993-07-08 | Warner-Lambert Company | Therapeutic combinations useful in the treatment of gastroesophageal reflux disease |
| HUP0402068A3 (en) * | 2001-11-13 | 2005-09-28 | Black James Foundation | Benzotriazepines as gastrin and cholecystokinin receptor ligands, process for their preparation and pharmaceutical compositions containing them |
| US7524837B2 (en) * | 2003-05-12 | 2009-04-28 | Janssen Pharmaceutica N.V. | Benzotriazapinone salts and methods for using same |
-
2004
- 2004-11-15 GB GB0425196A patent/GB0425196D0/en not_active Ceased
-
2005
- 2005-11-14 WO PCT/GB2005/004359 patent/WO2006051312A1/en not_active Ceased
-
2007
- 2007-06-15 GB GB0711660A patent/GB2435190A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2435190A (en) | 2007-08-15 |
| WO2006051312A1 (en) | 2006-05-18 |
| GB0711660D0 (en) | 2007-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL179694A0 (en) | Crth2 receptor ligands for medicinal uses | |
| PT2653465T (en) | Opioid receptor modulators | |
| GB0400440D0 (en) | Receptor modulators | |
| ZA200704223B (en) | Estrogen receptor modulators | |
| IL182829A0 (en) | Estrogen receptor modulators | |
| PL376702A1 (en) | Melanocortin receptor ligands | |
| GB0711660D0 (en) | Gastrin and cholecystokinin receptor ligands | |
| EP1898962A4 (en) | Gastrin releasing peptide compounds | |
| IL164766A0 (en) | Melanocortin receptor ligands | |
| IL161330A0 (en) | Benzotriazepines as gastrin and cholecystokinin receptor ligands | |
| GB0310865D0 (en) | Gastrin and cholecystokinin receptor ligands | |
| PL1648899T3 (en) | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands | |
| GB0310864D0 (en) | Gastrin and cholecystokinin receptor ligands | |
| GB0414798D0 (en) | Receptor | |
| SI1648899T1 (en) | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands | |
| IL175785A0 (en) | Gastrin releasing peptide compounds | |
| GB0413872D0 (en) | Receptor | |
| GB0416592D0 (en) | Mat | |
| GB0321998D0 (en) | Receptor | |
| GB0417119D0 (en) | Receptor | |
| GB0413096D0 (en) | Receptor | |
| GB0404584D0 (en) | Receptor | |
| GB0404309D0 (en) | Receptor | |
| GB0423327D0 (en) | Receptor | |
| GB0427025D0 (en) | Receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |